Reaction

Eye Contusion reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,080 reports · 73 co-occurring drugs

As of the last recalculation, Eye Contusion appears in 2,080 FAERS reports alongside 73 co-occurring drug terms. The strongest observed disproportionality signal is CENEGERMIN-BKBJ (PRR 28.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Cenegermin-Bkbj	34	28.6	28.7
Human Immunoglobulin G	30	14.7	14.8
Calcium, Magnesium, Potassium, And Sodium Oxybates	12	14.0	14.0
Diphenhydramine Hydrochloride Capsule, Liquid Filled	27	12.8	12.8
Lanreotide Acetate	9	11.5	11.5
Primidone	11	10.9	10.9
Lisinopril And Hydrochlorothiazide Tablets	8	10.2	10.2
Cenobamate	8	9.6	9.6
Octreotide Acetate	28	9.3	9.3
Rabeprazole	20	9.1	9.1
Botulinum Toxin Type A	11	8.9	8.9
Butalbital, Acetaminophen, And Caffeine	9	8.5	8.5
Onabotulinumtoxina	63	8.4	8.4
Ranibizumab	22	8.4	8.4
Adrenalinum	33	8.1	8.1
Lisinopril And Hydrochlorothiazide	8	7.9	7.9
Cetirizine Hcl	7	7.7	7.7
Methocarbamol	17	7.5	7.6
Emicizumab	9	7.3	7.3
Modafinil	22	6.9	6.9
Sodium Oxybate	44	6.8	6.8
Diroximel Fumarate	8	6.7	6.7
Avapritinib	8	6.6	6.6
Mupirocin Calcium	9	6.6	6.6
Amantadine	10	6.5	6.5
Carboxymethylcellulose Sodium	6	6.4	6.4
Buspirone Hydrochloride	7	6.4	6.4
Lifitegrast	10	6.1	6.2
Benzonatate	10	6.1	6.1
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	21	6.0	6.0
Armodafinil	12	5.7	5.7
Siponimod	5	5.6	5.6
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate	21	5.1	5.1
Ethyl Alcohol	13	4.8	4.8
Naltrexone Hydrochloride And Bupropion Hydrochloride	4	4.7	4.7
Teriflunomide	21	4.7	4.7
Macitentan	32	4.7	4.7
Selexipag	12	4.7	4.7
Suvorexant	6	4.6	4.6
Ibrutinib	36	4.5	4.5
Aflibercept	14	4.5	4.5
Brimonidine Tartrate	8	4.5	4.5
Brivaracetam	4	4.5	4.5
Nintedanib	13	4.2	4.2
Rotigotine	6	4.2	4.2
Riociguat	13	4.0	4.0
Romiplostim	6	4.0	4.0
Ruxolitinib	28	3.9	4.0
Isopropyl Alcohol	13	3.9	3.9
Budesonide, Glycopyrrolate, And Formoterol Fumarate	4	3.8	3.8
Bimatoprost	11	3.8	3.8
Linaclotide	10	3.8	3.8
Treprostinil	46	3.7	3.7
Faricimab	3	3.7	3.7
Teriparatide	40	3.6	3.6
Alcohol	13	3.4	3.4
Acalabrutinib	4	3.3	3.3
Risankizumab-Rzaa	26	3.2	3.2
Rimegepant Sulfate	4	3.2	3.2
Dalfampridine	22	3.1	3.1
Peginterferon Beta-1A	4	3.1	3.1
Cannabidiol	7	3.0	3.0
Ambrisentan	35	2.8	2.8
Fremanezumab-Vfrm	3	2.6	2.6
Tafamidis	3	2.6	2.6
Glatiramer Acetate	15	2.5	2.5
Sacubitril And Valsartan	28	2.4	2.4
Pimavanserin Tartrate	13	2.4	2.4
Velpatasvir And Sofosbuvir	3	2.3	2.3
Droxidopa	5	2.3	2.3
Valbenazine	4	1.6	1.6
Dupilumab	61	1.3	1.3
Adapalene	7	0.4	0.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.